Download PDF Flyer
Impact Factor Current: 3.465
5 - Year: 3.758

Current Drug Targets

ISSN (Print): 1389-4501
ISSN (Online): 1873-5592

Volume 23 , Issue 17 , 2022

This journal supports open access

Back Journal Home
Impact Factor
Web of Science Impact Factor

Current: 3.465
5 - Year: 3.758

Ranking & Category

  • 131st of 267 in Pharmacology & Pharmacy

Topic(s) Covered

1 Topic(s)

View
Covered Disease(s)

0 Disease(s)

Aims & Scope

Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes.

Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication full-length/mini review articles and drug clinical trial studies.

As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Abstracted/Indexed in


Biochemistry & Biophysics Citation Index®, BIOSIS, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, British Library, Cambridge Scientific Abstracts (CSA)/ProQuest, Chemical Abstracts Service/SciFinder, ChemWeb, CNKI Scholar, Dimensions, EBSCO, EMBASE/Excerpta Medica, ERA 2018, Genamics JournalSeek, Google Scholar, InCites, Index Copernicus, Index to Scientific Reviews®, J-Gate, Journal Citation Reports/Science Edition, JournalTOCs, MediaFinder®-Standard Periodical Directory, MEDLINE/PubMed, Open Abstracts (I4OA), Norwegian Register, PubsHub, QOAM, Science Citation Index Expanded™ (SciSearch®), Scilit, Scopus, Suweco CZ, TOC Premier, and Ulrich's Periodicals Directory.

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.

Special Offers

Abstracted/Indexed in
COPE COMPLIANT
Endorsement(s)

"In view of the growing volume of literature, the role of high quality review journals has become increasingly important. Current Drug Targets is an important journal in the field of medicinal chemistry and drug design, which is strongly recommended to the scientific community."

Jean-Marie Lehn
Nobel Laureate

Authors' Comments

It was a nice experience to publish our article in current drug target. I felt that the journal is quick and has maintained very high standard by independently reviewing article from more than five reviewers. The communication between the author and the Journals editorial is also speedy. I hope the journal will continue to maintain and sustain its reputation. 

Pushpender K. Sharma
(Department of Biotechnology, Sri Guru Granth Sahib World University, Fatehgarh Sahib, Pb, India.)

© 2022 Bentham Science Publishers | Privacy Policy